The initial prognostic factors used included tumor size, nuclear and histologic grade, as well as biomarkers such as estrogen receptor (ER) and progesterone receptor (PR) status, human epidermal growth factor receptor 2 (HER2) amplification, and cathepsin D levels [1–5]. The gene discussed is PGR; the disease is neoplasm.